The study’s senior author, Michael P. Steinmetz, MD, Director of the Center for Spine Health at Cleveland Clinic, says “These two-year results were key to FDA approval of the TOPS System as the first alternative to spinal fusion for grade I degenerative spondylolisthesis.”
The FDA approved the first device that uses facet joint replacement to treat degenerative spondylolisthesis with lumbar spinal stenosis.